Outlook Therapeutics (41O.F) Q2 2024 Earnings

15MayConfirmed
Q2 2024
-1.42
-1.23
-1.03
-0.84

Details

Expected EPS
-0.8355793680000001
Actual EPS
-1.423396
Surprise EPS
-0.59
Surprise Percent
+70.35%

Description

Outlook Therapeutics (41O.F) has reported earnings of -1.423396 per share for Q2 2024.

0 Comments

Share your thoughts